IMM 6.33% 42.0¢ immutep limited

PBS, Keytruda and NSCLC....

  1. 25,290 Posts.
    lightbulb Created with Sketch. 1369
    Just on radio, keytruda approved for PBS, tidying up loose ends with MSD (Mercks arm in Aust.)
    Keytruda has 37% success rate in mono treatment......Remember, Immutep and efti about to start
    combo trials in US for non small cell lung cancer with keytruda....Places a bit more interest in
    tacti-mel melanoma combo trials too in my opinion.....
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
42.0¢
Change
0.025(6.33%)
Mkt cap ! $598.3M
Open High Low Value Volume
39.5¢ 42.0¢ 39.5¢ $890.1K 2.163M

Buyers (Bids)

No. Vol. Price($)
3 127863 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 30850 2
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.